Surya Mohapatra
Surya N. Mohapatra, Ph.D., has held senior leadership positions in the health care industry for more than 35 years, most recently as the Chairman, President and Chief Executive Officer of Quest Diagnostics Incorporated, a world leader in diagnostic testing, information and services where he had been a senior executive from1999 to 2012. He has been a strong advocate of patient empowerment and accountability to improve healthcare and reduce costs. Prior to joining Quest Diagnostics, he served as Senior Vice President and a member of the Executive Committee of Picker International, now part of Philips Medical Systems, where he played an important role in the design, manufacture and commercialization of Magnetic Resonance Imaging during his 19 year tenure.
Dr. Mohapatra is a past Board member of the ITT Corporation, and of Xylem Inc., a leading global water technology and transport company. He was the founding Chairman of HCL Healthcare India Pvt Ltd.. He is currently a Board member of Leidos Inc., a science and technology solutions leader in the defense, intelligence, homeland security, civil, and healthcare sectors. Dr. Mohapatra is active in a number of not for profit institutions. He is a Trustee of the Rockefeller University, the Valley Hospital Foundation, and an Executive in Residence at the Columbia Business School. He is also a Board member of Malaria No More, a nonprofit organization that aims to end deaths caused by Malaria; and Safe Water Networks that promotes social entrepreneurship to provide safe, affordable water to people in need.
Dr. Mohapatra received B.Sc.Eng. in Electrical Engineering in1971 from the National Institute of Technology, Rourkela, India and was conferred Distinguished Alumnus Award in 2011. He holds a Master of Science in Medical Electronics from the University of Salford, England; and a Doctorate in Medical Physics from the University of London and the Royal College of Surgeons of England. He is the author of several publications and patents including the book “ Noninvasive Cardiovascular Monitoring by Electrical Impedance Technique”